Fibrocystic disorders of the breast

The fibrocystic changes of the breast constitute a clinical entity that has no clear etiopathogeny, although it is thought that the persistent estrogenic stimulus may be the cause, but there are other hypothesis related to consumption of saturated fats and use of methylxanthines. The diagnosis is ba...

Full description

Saved in:
Bibliographic Details
Published inGinecologia y obstetricia de Mexico Vol. 66; pp. 362 - 366
Main Authors Tserotas, K, Morán Villota, C
Format Journal Article
LanguageSpanish
Published Mexico 01.09.1998
Subjects
Female
Fibrocystic Breast Disease - diagnosis
Fibrocystic Breast Disease - drug therapy
Fibrocystic Breast Disease - etiology
Humans
Online AccessGet full text

Cover

More Information
Summary:The fibrocystic changes of the breast constitute a clinical entity that has no clear etiopathogeny, although it is thought that the persistent estrogenic stimulus may be the cause, but there are other hypothesis related to consumption of saturated fats and use of methylxanthines. The diagnosis is based on the presence of breast pain and nodularity, usually before the onset of menses. General measures, as avoidance of methylxanthines, lower body weight and a firm brassiere are efficacious but some cases require biopsy to discard other problems and use of pharmacologic therapy as danazol, tamoxifen, or bromocriptine.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ISSN:0300-9041